Armonk, NY, United States of America

Paula Dakin

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Inventor Spotlight: Paula Dakin**

Introduction

Paula Dakin, an accomplished inventor based in Armonk, NY, has made significant contributions to the field of pharmaceutical sciences. With a focus on innovative treatments for pain management, she holds a patent that showcases her commitment to improving patient outcomes, particularly for those suffering from knee and hip pain.

Latest Patents

Paula Dakin is credited with one notable patent titled, "Pharmaceutical composition for safe and effective treatment of knee and/or hip pain." This invention describes a pharmaceutical composition and method aimed at treating patients who are non-responsive or intolerant to standard analgesic therapies. The patent also outlines a method for mitigating the risk of developing arthropathy in subjects receiving an anti-NGF antibody for knee and/or hip pain treatment. Specifically, it is applicable to patients with osteoarthritis, utilizing fasinumab as the anti-NGF antibody. Furthermore, the patent includes methods for monitoring the safety of this treatment regimen.

Career Highlights

Dakin's career is marked by her role at Regeneron Pharmaceuticals, Inc., a leading biopharmaceutical company known for its cutting-edge research and development in various therapeutic areas. At Regeneron, she has had the opportunity to work on groundbreaking pharmaceutical advancements, contributing to innovative solutions in pain management.

Collaborations

Throughout her career, Paula has collaborated with esteemed colleagues including Gregory P. Geba and Stephen DiMartino. Their combined expertise and efforts reflect a team-oriented approach to research and development that is pivotal for advancing healthcare solutions.

Conclusion

Paula Dakin exemplifies the spirit of innovation in the pharmaceutical industry. Through her patent for treating knee and hip pain, she has showcased the potential for new therapeutic options that enhance patient care. As she continues her work at Regeneron Pharmaceuticals, her contributions pave the way for future advancements in pain management and overall healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…